Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe (BfArM)

Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe is the official source of medicine shortage information for Germany (EU). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.bfarm.de

Country

Germany

Notices tracked by Mederti

1,103

Last checked

8 Nov 2026

Latest notices from BfArM

• Esmololhydrochlorid — anticipated, high, since 1 May 2027 (source)
• Pentostatin — anticipated, high, since 1 Mar 2027 (source)
• Ciprofloxacinhydrochlorid-Monohydrat — anticipated, medium, since 4 Dec 2026 (source)
• Etoricoxib — anticipated, medium, since 4 Dec 2026 (source)
• Calciumchlorid-Dihydrat; Histidin; Histidinhydrochlorid-Monohydrat; Kalium-Hydrogen-2-Oxopentandioat; Kaliumchlorid; Magnesiumchlorid-Hexahydrat; Mannitol (Ph.Eur.); Natriumchlorid; Tryptophan — anticipated, medium, since 30 Nov 2026 (source)
• Isoflurane(100%) — anticipated, high, since 16 Nov 2026 (source)
• Encorafenib — anticipated, medium, since 16 Nov 2026 (source)
• Indapamide-Hemihydrate — active, medium, since 6 Nov 2026 (source)
• Clindamycinhydrochlorid — active, medium, since 5 Nov 2026 (source)
• Filgrastim — active, medium, since 5 Nov 2026 (source)
• Clindamycin-2-Dihydrogenphosphat; Tretinoin — active, high, since 5 Nov 2026 (source)
• Clonidinhydrochlorid — active, medium, since 5 Nov 2026 (source)
• Sulfamethoxazole And Trimethoprim Tablets — active, medium, since 5 Nov 2026 (source)
• Paliperidon — active, medium, since 3 Nov 2026 (source)
• Entecavir-Monohydrat — active, medium, since 3 Nov 2026 (source)

Mederti is not affiliated with or endorsed by Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe. All notices remain the property of their publisher and are linked to the original source.